1 - 25 of 575 results for author:"Yamamoto H." in Literature citations
Results Customize
› Repeat search in UniProtKB (4,850)
| Hepatitis E virus outbreak in monkey facility, Japan. Yamamoto H., Suzuki J., Matsuda A., Ishida T., Ami Y., Suzaki Y., Adachi I., Wakita T., Takeda N., Li T.C. Emerging Infect. Dis. 18:2032-2034(2012) · UniProtKB (3) |
| Membrane protein Rim21 plays a central role in sensing ambient pH in Saccharomyces cerevisiae. Obara K., Yamamoto H., Kihara A. J. Biol. Chem. 287:38473-38481(2012) |
| Composition and physiological function of the chloroplast NADH dehydrogenase-like complex in Marchantia polymorpha. Ueda M., Kuniyoshi T., Yamamoto H., Sugimoto K., Ishizaki K., Kohchi T., Nishimura Y., Shikanai T. Plant J. 72:683-693(2012) · UniProtKB (20) |
| Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions. Mikami N., Watanabe K., Hashimoto N., Miyagi Y., Sueda K., Fukada S., Yamamoto H., Tsujikawa K. Int. Immunol. 24:681-691(2012) · Mapped (5) |
| RsfA (YbeB) proteins are conserved ribosomal silencing factors. Hauser R., Pech M., Kijek J., Yamamoto H., Titz B., Naeve F., Tovchigrechko A., Yamamoto K., Szaflarski W., Takeuchi N. et al. PLoS Genet. 8:E1002815-E1002815(2012) · UniProtKB (12) |
| LRH-1-dependent glucose sensing determines intermediary metabolism in liver. Oosterveer M.H., Mataki C., Yamamoto H., Harach T., Moullan N., van Dijk T.H., Ayuso E., Bosch F., Postic C., Groen A.K. et al. J. Clin. Invest. 122:2817-2826(2012) · Mapped (4) |
| Structural insights into Atg10-mediated formation of the autophagy-essential Atg12-Atg5 conjugate. Yamaguchi M., Noda N.N., Yamamoto H., Shima T., Kumeta H., Kobashigawa Y., Akada R., Ohsumi Y., Inagaki F. Structure 20:1244-1254(2012) · UniProtKB (1) |
| The complex of tmRNA-SmpB and EF-G on translocating ribosomes. Ramrath D.J., Yamamoto H., Rother K., Wittek D., Pech M., Mielke T., Loerke J., Scheerer P., Ivanov P., Teraoka Y. et al. Nature 485:526-529(2012) · Mapped (49) |
| Impaired development of melanoblasts in the black-eyed white Mitf(mi-bw) mouse, a model for auditory-pigmentary disorders. Hozumi H., Takeda K., Yoshida-Amano Y., Takemoto Y., Kusumi R., Fukuzaki-Dohi U., Higashitani A., Yamamoto H., Shibahara S. Genes Cells 17:494-508(2012) · Mapped (8) |
| Association between plasma high-molecular-weight adiponectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulation. Kunita E., Yamamoto H., Kitagawa T., Ohashi N., Utsunomiya H., Oka T., Horiguchi J., Awai K., Kihara Y. Circ. J. 76:1687-1696(2012) · Mapped (3) |
| HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study. Hashimoto K., Yamamoto H., Shiratsuchi H., Nakashima T., Tamiya S., Nishiyama K., Higaki Y., Komune S., Tsuneyoshi M., Oda Y. Histopathology 60:E131-42(2012) · Mapped (8) |
| CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Kitade H., Sawamoto K., Nagashimada M., Inoue H., Yamamoto Y., Sai Y., Takamura T., Yamamoto H., Miyamoto K., Ginsberg H.N. et al. Diabetes 61:1680-1690(2012) · Mapped (2) |
| C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer. Oshiro R., Yamamoto H., Takahashi H., Ohtsuka M., Wu X., Nishimura J., Takemasa I., Mizushima T., Ikeda M., Sekimoto M. et al. Cancer Sci. 103:1155-1164(2012) · Mapped (4) |
| Copy number variations due to large genomic deletion in X-linked chronic granulomatous disease. Arai T., Oh-ishi T., Yamamoto H., Nunoi H., Kamizono J., Uehara M., Kubota T., Sakurai T., Kizaki T., Ohno H. PLoS ONE 7:e27782-e27782(2012) · Mapped (4) |
| Stanniocalcin 2 is associated with ectopic calcification in alpha-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells. Takei Y., Yamamoto H., Sato T., Otani A., Kozai M., Masuda M., Taketani Y., Muto-Sato K., Lanske B., Takeda E. Bone 50:998-1005(2012) · Mapped (8) |
| Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylation. Uranbileg B., Yamamoto H., Park J.H., Mohanty A.R., Arakawa-Takeuchi S., Jinno S., Okayama H. J. Biol. Chem. 287:6275-6283(2012) · Mapped (2) |
| RAGE mediates vascular injury and inflammation after global cerebral ischemia. Kamide T., Kitao Y., Takeichi T., Okada A., Mohri H., Schmidt A.M., Kawano T., Munesue S., Yamamoto Y., Yamamoto H. et al. Neurochem. Int. 60:220-228(2012) · Mapped (20) |
| Canonical Wnt signaling in the visceral muscle is required for left-right asymmetric development of the Drosophila midgut. Kuroda J., Nakamura M., Yoshida M., Yamamoto H., Maeda T., Taniguchi K., Nakazawa N., Hatori R., Ishio A., Ozaki A. et al. Mech. Dev. 128:625-639(2012) · Mapped (33) |
| Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Congrains A., Kamide K., Oguro R., Yasuda O., Miyata K., Yamamoto E., Kawai T., Kusunoki H., Yamamoto H., Takeya Y. et al. Atherosclerosis 220:449-455(2012) · Mapped (6) |
| Diabetes alters subsets of endothelial progenitor cells that reside in blood, bone marrow, and spleen. Saito H., Yamamoto Y., Yamamoto H. Am. J. Physiol., Cell Physiol. 302:C892-901(2012) · Mapped (6) |
| Toll-like receptor 9-dependent activation of bone marrow-derived dendritic cells by URA5 DNA from Cryptococcus neoformans. Tanaka M., Ishii K., Nakamura Y., Miyazato A., Maki A., Abe Y., Miyasaka T., Yamamoto H., Akahori Y., Fue M. et al. Infect. Immun. 80:778-786(2012) · Mapped (1) |
| An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Hanaki H., Yamamoto H., Sakane H., Matsumoto S., Ohdan H., Sato A., Kikuchi A. Mol. Cancer Ther. 11:298-307(2012) · Mapped (9) |
| Waif1/5T4 inhibits Wnt/beta-catenin signaling and activates noncanonical Wnt pathways by modifying LRP6 subcellular localization. Kagermeier-Schenk B., Wehner D., Ozhan-Kizil G., Yamamoto H., Li J., Kirchner K., Hoffmann C., Stern P., Kikuchi A., Schambony A. et al. Dev. Cell 21:1129-1143(2011) · Mapped (6) |
| PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection. Noda T., Yamamoto H., Takemasa I., Yamada D., Uemura M., Wada H., Kobayashi S., Marubashi S., Eguchi H., Tanemura M. et al. Liver Int. 32:110-118(2012) · Mapped (6) |
| NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Yamamoto H., Williams E.G., Mouchiroud L., Canto C., Fan W., Downes M., Heligon C., Barish G.D., Desvergne B., Evans R.M. et al. Cell 147:827-839(2011) · Mapped (25) |